无皮肤硬化的系统性硬化症:来自意大利风湿病学会全国SPRING注册库大样本患者的临床与血清学特征及与其他皮肤亚型的比较
基于意大利SPRING注册库1808例系统性硬化症患者,仅61例(3.4%)符合无皮肤硬化的系统性硬化症(ssSSc)。ssSSc从雷诺现象到诊断的时间长于局限皮肤型(lcSSc)和弥漫皮肤型(dcSSc),临床表型与lcSSc可比,但显著轻于dcSSc,抗着丝点抗体阳性率与lcSSc相当而与dcSSc不同。
要点
- ssSSc仅占系统性硬化症患者的3.4%(61/1808),从雷诺现象到诊断的时间较lcSSc和dcSSc更长。
- ssSSc临床表型与lcSSc可比(除指端凹陷性瘢痕较少),但显著轻于dcSSc。
- ssSSc抗着丝点抗体阳性率与lcSSc相当,与dcSSc差异显著。
核心结论
- ssSSc是相当罕见的疾病变异型,其临床血清学特征与lcSSc可比但与dcSSc显著不同。
- 较长的雷诺现象病程、较低的指端凹陷性瘢痕和外周微血管异常比例以及较高的抗着丝点抗体阳性率可区分ssSSc。
研究设计与样本
- 收集意大利系统性硬化症进展调查(SPRING)注册库中1808例系统性硬化症患者的数据。
- ssSSc定义为无任何皮肤硬化及无肿胀手指。
- 将ssSSc的临床与血清学特征与局限皮肤型(lcSSc)和弥漫皮肤型(dcSSc)亚型进行比较。
主要发现
- 1808例系统性硬化症患者中仅61例(3.4%)被分类为ssSSc(女/男=19/1)。
- 从雷诺现象起病到诊断的时间ssSSc为3年(IQR 1-16.5),长于lcSSc的2年(IQR 0-7)和dcSSc的1年(IQR 0-3)(p<0.001)。
- 指端凹陷性瘢痕ssSSc为19.7% vs lcSSc 42%(p=0.01)。
- 指端溃疡ssSSc为6.6% vs dcSSc 35.7%(p<0.001),食管受累ssSSc为46.2% vs dcSSc 63.5%(p=0.009)。
- 肺功能ssSSc vs dcSSc:平均一氧化碳弥散量72.2±19.6 vs 62.4±22.8(p=0.009);平均用力肺活量105.6±21.7 vs 89.2±20.9(p<0.001)。
局限性
- 原文结论指出基于国家注册库的进一步研究可能为ssSSc在硬皮病谱系中的实际相关性提供有用见解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe demographic, clinical and laboratory features of systemic sclerosis sine scleroderma (ssSSc) in a large multicentre systemic sclerosis (SSc) cohort. METHODS: Data involving 1808 SSc patients from Italian Systemic sclerosis PRogression INvestiGation registry were collected. The ssSSc was defined by the absence of any cutaneous sclerosis and/or puffy fingers. Clinical and serological features of ssSSc were compared with limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) subsets. RESULTS: Among patients with SSc, only 61 (3.4%) were classified as having ssSSc (F/M=19/1). Time from Raynaud's phenomenon (RP) onset to diagnosis was longer in ssSSc (3 years, IQR 1-16.5) than lcSSc (2 years, IQR 0-7), and dcSSc (1 year, IQR 0-3) (p<0.001). Clinical ssSSc phenotype was comparable to lcSSc, except for digital pitting scars (DPS) (19.7% vs 42%, p=0.01), but significantly milder than dcSSc, particularly for digital ulcers (DU) (6.6% vs 35.7%, p<0.001), oesophagus (46.2% vs 63.5%, p=0.009), lung (mean diffusion capacity for carbon monoxide 72.2±19.6 vs 62.4±22.8, p=0.009; mean forced vital capacity 105.6±21.7 vs 89.2±20.9, p<0.001) and major videocapillaroscopic alterations (late pattern 8.6% vs 47.6%, p<0.001). Moreover, in ssSSc the percentages of anticentromere and antitopoisomerase were comparable to lcSSc (40% and 18.3% vs 36.7% and 26.6%), but divergent respect to dcSSc (8.6% and 67.4%, p<0.001). CONCLUSION: The ssSSc is a quite rare disease variant characterised by clinico-serological features comparable to lcSSc, but significantly different from dcSSc. Overall, longer RP duration, low percentages of DPS and peripheral microvascular abnormalities, and increased anti-centromere seropositivity distinguish ssSSc. Further investigations based on national registries might provide useful insights on the actual relevance of the ssSSc within the scleroderma spectrum.
引用
- De Angelis R, Ferri C, Giuggioli D, et al. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology. RMD Open. 2023. PMID: 36868782. doi:10.1136/rmdopen-2022-002890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。